Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go:
Expired
investment:
Withheld
Targeting heavy-duty diesel engines the Cibus21 retrofit technology system claims it is fuel-saving and reduces harmful exhaust emissions through the principle of Enhanced Combustion. With patents pending the company claims the enhanced combustion process introduces small amounts of LPG directly into the diesel engines' air intake to fundamentally change the chemistry of the combustion process. The company states that the current experienced efficiency gains are 15-20% reduced in diesel use and CO2 emissions.
days to go:
Expired
investment:
£116,000
Cipher Surgical has developed a unique piece of technology to make keyhole surgery (laparoscopy) quicker and safer for both surgeons and patients.
days to go:
Expired
investment:
£1,825,399
Cipher Surgical have developed a new product that is designed to remove contaminants from the laparoscope’s lens during keyhole surgery, thus removing the need to constantly take the laparascope out of the patient for cleaning. This is done by manipulating CO2 and saline across the lens and therefore removing blood, peritoneal fluid, particulate matter and condensation/fogging from the lens.
days to go:
Expired
investment:
£175,000
Co-Space is a forward-thinking flexible office operator with a focus on affluent towns and cities outside Central London. Established in 2018, Co-Space has thrived even during the pandemic, boasting two successful sites in Reading (95% occupied) and Stevenage (93% occupied). Our approach involves transforming underutilized spaces into highly sought-after flexible offices, incorporating exceptional interior design and dedicated service. With a revenue run rate of £1.5 million and over 90% of it being contracted and recurring, Co-Space is a promising contender, bridging the gap between exceptional London design and regional competition.
days to go:
Expired
investment:
£50,000
Cyance is an award-winning marketing technology pioneer. Nexus is a software platform designed by the company to track the buying behaviour through billions of computers belonging to millions of businesses across the globe. This platform can track the consumed content and identifies customer interests and needs. The company's customers typically generate x3 more leads and x4 more sales. With the proceeds, Cyance will increase its marketing sales and improve product development to fund the general working capital.
days to go:
Expired
investment:
Withheld
DABBOUS is a highly successful, Michelin starred, modern fine-dining restaurant and bar in central London. Opened in January 2012 by Ollie Dabbous and Oskar Kinberg, DABBOUS offers innovative style and creative interpretation of modern European cuisine in an industrial setting.
days to go:
Expired
investment:
£3,124,165
DotFrames is pioneering an AI, VR, and AR-powered e-commerce platform for immersive 3D experiences. Their focus is on media and entertainment, creating hyper-real galleries for art and collectibles. They aim to develop a next-gen Shopify platform-as-a-service, enabling clients to showcase and sell various products in immersive environments. The investment will fuel platform development. DotFrames merges technology and artistry, reshaping art appreciation.
days to go:
Expired
investment:
£100,000
Metal matrix composite components and materials, primarily comprised of aluminium for use in the engineering and manufacturing industries. Alvant specialise in designing, developing and producing the composite for well-known clients such as Ford and Safran.
In the last financial year, Alvant achieved a turnover of almost £617k and has invested more than £10m towards manufacturing and testing their own product. Alvant is now raising funds to distribute their components to a wider market and expand the number of commercial applications that would benefit from their materials.
days to go:
Expired
investment:
£2,105,001
EarlyBird have created a number of different healthy snack packs, all made with fresh ingredients. EarlyBird deliver their snacks straight to your door meaning you don't have to leave the comfort of your home.
days to go:
Expired
investment:
£168,000
